Chen, Xi External Author

Publications

Sort by

Selected publications

  • EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinibJournal of Thoracic Oncology2012 Academic Article GET IT
    Times cited: 14